Customer Success Story: Clean Core DNA: Belenos on SAP Cloud.

Customer Success Story: Clean Core DNA: Belenos on SAP Cloud.

Reading time: 2 mins

Customer Belenos Bioscience
Industry: Biotech
Key technologies: SAP S/4HANA Cloud, SAP Concur
Go-live: 03/2025
Country: United States of America
Belenos Bioscience, a biotech startup founded in 2024, raised seed funding to develop long-acting bispecific antibodies with half-life extension technology, aiming to deliver pipeline-in-a-product therapies for chronic inflammatory diseases.
To meet investor expectations and prepare for IPO readiness, Belenos partnered with Westernacher Consulting to implement SAP S/4HANA Cloud Public Edition.
  • Reduced manual reconciliations by 60–70%
  • SAP solutions implementation in just 12 weeks
  • R&D cost tracking accuracy: >95%
In just 12 weeks, the SAP Gold Partner Westernacher Consulting replaced manual processes with automated, scalable systems, integrating SAP Concur for spend management and embedding SOX/SSAE18 controls. The transformation enabled GAAP-aligned financials, reduced manual reconciliations by up to 70%, and achieved >95% accuracy in R&D cost tracking.
With a clean digital core and enterprise-grade governance, Belenos is now focused on growth and discovery.
About Belenos – Driving next-generation antibody development.
Belenos Bio Science, a New York-based biotech company founded in 2024, has secured approx. $55 million seed funding to advance specifically long-acting bispecific antibodies engineered as pipeline-in-a-product therapies with half-life extension technology, enabling patients suffering from chronic inflammatory diseases, deeper, more durable disease control and improved patient adherence with therapies.
The Challenge – From spreadsheets to compliance-ready systems.
The biotech company needed GAAP-aligned, IPO-ready reporting; SOX/SSAE18 controls from day one; a digital audit trail; and the ability to scale processes without increasing manual workloads.
Initially, early financial operations ran on spreadsheets and shared folders, which was sufficient. However, as investor expectations increased, issues began to arise. And it was really important to make sure that Belenos could complete the implementation quickly to file taxes on time.
Sam Amoresano, Controller at Belenos Bioscience, explains:
Now, I’m able to produce a trial balance. I’m able to produce financials for our investors. Those were real deadlines that I had to meet.

What was the Westernacher Consulting approach?

With over 30 years’ experience working with SAP, Westernacher Consulting was able to provide best practices and preconfigured content tailored to the finance and procurement needs of the biotech industry.
  • SAP S/4HANA Cloud Public Edition became the single source of truth.
  • SAP Concur integrated T&E and supplier spend with policy enforcement, automated receipt capture and straight-through posting to S/4HANA.
  • Automated controls, workflows, and approvals replaced email chains and master data governance with reduced variance and rework.

All of this was implemented in just 12 weeks, preserving agility while establishing enterprise-grade control.

The Result – Outcomes that matter.

Financials that are GAAP-aligned and ready for assurance, suitable for an IPO path.
Reduced manual reconciliations by 60–70% by replacing spreadsheets with governed processes.
Embedded automated SOX/SSAE18 controls and a digital audit trail;
Captured R&D costs with >95% accuracy to support tax rebate reporting.
Standardized core finance and procurement processes to enable scaling with growth.
Tania Dimitrova, Chief Financial Officer of Belenos Biosciences, says:
I’ve never seen or heard of another company of our size at our stage of development, just one year and a half of existence, filing their first tax returns with a system like SAP in place.
Lessons learned – The focus is now on growth.
With Westernacher Consulting and SAP S/4HANA Cloud at the core, the company is ready for every step of the journey. With a solid and robust technological core, cleaner data and stronger governance, Belenos Bioscience is ready to focus on driving towards commercial launch.

More Resources

See All Related Content